Huntsman CORP (HUN) stock
HUNNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/3017% above fair value
$9.53−0.13 (-1.35%)
Close on Nov 13, 2026Market cap $1.67BP/E –Yield 8.79%
Huntsman EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Huntsman's EPS for the twelve months ending Jun 30, 2026 was -$1.04. For fiscal 2025 it was -$1.65. The highest annual figure on record is $4.72 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.65 | – |
| FY2024 | Dec 31, 2024 | -$1.10 | -293.0% |
| FY2023 | Dec 31, 2023 | $0.57 | -74.9% |
| FY2022 | Dec 31, 2022 | $2.27 | -51.9% |
| FY2021 | Dec 31, 2021 | $4.72 | +1.3% |
| FY2020 | Dec 31, 2020 | $4.66 | +91.0% |
| FY2019 | Dec 31, 2019 | $2.44 | +75.5% |
| FY2018 | Dec 31, 2018 | $1.39 | -46.7% |
| FY2017 | Dec 31, 2017 | $2.61 | +91.9% |
| FY2016 | Dec 31, 2016 | $1.36 | +257.9% |
| FY2015 | Dec 31, 2015 | $0.38 | -71.0% |
| FY2014 | Dec 31, 2014 | $1.31 | +147.2% |
| FY2013 | Dec 31, 2013 | $0.53 | -64.9% |
| FY2012 | Dec 31, 2012 | $1.51 | +48.0% |
| FY2011 | Dec 31, 2011 | $1.02 | +827.3% |
| FY2010 | Dec 31, 2010 | $0.11 | -77.1% |
| FY2009 | Dec 31, 2009 | $0.48 | -81.5% |
| FY2008 | Dec 31, 2008 | $2.60 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.03 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.31 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.56 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.14 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.92 | -807.7% |
| Q1 FY2025 | Mar 31, 2025 | -$0.03 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.82 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.19 | -122.9% |
| Q2 FY2024 | Jun 30, 2024 | $0.13 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.22 | -144.0% |
| Q4 FY2023 | Dec 31, 2023 | -$0.42 | -138.2% |
| Q1 FY2023 | Mar 31, 2023 | $0.83 | -20.2% |
| Q4 FY2022 | Dec 31, 2022 | -$0.48 | -117.6% |
| Q3 FY2022 | Sep 30, 2022 | $0.50 | -46.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.10 | +57.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.04 | +181.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.73 | +79.6% |
| Q3 FY2021 | Sep 30, 2021 | $0.94 | +327.3% |
| Q2 FY2021 | Jun 30, 2021 | $0.70 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.37 | -88.3% |
| Q4 FY2020 | Dec 31, 2020 | $1.52 | +13.4% |
| Q3 FY2020 | Sep 30, 2020 | $0.22 | +69.2% |
| Q2 FY2020 | Jun 30, 2020 | -$0.28 | – |
| Q1 FY2020 | Mar 31, 2020 | $3.16 | +216.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.34 | +123.3% |
| Q3 FY2019 | Sep 30, 2019 | $0.13 | -81.2% |
| Q4 FY2018 | Dec 31, 2018 | -$1.43 | -561.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.00 | +88.7% |
| Q3 FY2017 | Sep 30, 2017 | $0.60 | +160.9% |
| Q2 FY2017 | Jun 30, 2017 | $0.69 | +91.7% |
| Q1 FY2017 | Mar 31, 2017 | $0.31 | +29.2% |
| Q4 FY2016 | Dec 31, 2016 | $0.53 | +2550.0% |
| Q3 FY2016 | Sep 30, 2016 | $0.23 | +4.5% |
| Q2 FY2016 | Jun 30, 2016 | $0.36 | – |
| Q1 FY2016 | Mar 31, 2016 | $0.24 | – |
| Q4 FY2015 | Dec 31, 2015 | $0.02 | – |
| Q3 FY2015 | Sep 30, 2015 | $0.22 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?